Program

Korea Standard Time
Local Time

Invited Speakers




Plenary Lecture
Yuman Fong, MD, ScD (Hon) CV
City of Hope Medical Center, USA
Viral and cellular immunotherapeutics for cancer: From research to clinical care



Waun Ki Hong Memorial Lecture
Carl H. June, MD CV
University of Pennsylvania School of Medicine, USA
Chimeric antigen receptor therapy - Clinical perspective and significance


Educational Sessions (ES)

ES1. Function preserving curable surgery for solid cancer
11/12(T) 15:20-17:00
cv
Sung-Bum Kang
Seoul National University College of Medicine
cv
Joo Hyoung Kim
Pusan National University School of Medicine
cv
Ji Yeong An
Sungkyunkwan University School of Medicine

ES2. Recent update of particle radiation therapy
11/13(F) 15:10-16:50
cv
Woong Sub Koom
Yonsei University College of Medicine
cv
Haksoo Kim
National Cancer Center
cv
Do Hoon Lim
Sungkyunkwan University School of Medicine
cv
Hong-Gyun Wu
Seoul National University College of Medicine


Young Investigator Symposia (YIS)

YIS1. Young Investigator Symposium I
11/12(T) 13:30-15:10
cv
Youngju Park
Seoul St. Mary’s Hospital, The Catholic University of Korea
cv
Sung Hwan Lee
CHA University School of Medicine
cv
Yoo-Young Lee
Samsung Medical Center

YIS2. Young Investigator Symposium II
11/13(F) 13:20-15:00
cv
Choong-kun Lee
Yonsei University College of Medicine
cv
Jong-ho Cha
Inha University School of Medicine
cv
Yoon Sun Choi
Inje University Busan Paik Hospital
cv
Eun Kyung Choe
Seoul National University Hospital, Healthcare System Gangnam Center


Symposia (SP)

SP1. Histology-agnostic treatment approach
11/12(T) 10:30-12:10
cv
David S. Hong
MD Anderson Cancer Center, USA
cv
Hussein A. Tawbi
MD Anderson Cancer Center, USA
cv
Sae-Won Han
Seoul National University Hospital
cv
Yeon Hee Park
Sungkyunkwan University School of Medicine

SP2. Systems biologic approach to cancer genomics
11/12(T) 10:30-12:10
cv
Young Seok Ju
Korea Advanced Institute of Science and Technology (KAIST)
cv
Sangwoo Kim
Yonsei University College of Medicine
cv
Wonshik Han
Seoul National University College of Medicine
cv
Jae Kyung Won
Seoul National University College of Medicine

SP3. Adolescents and young adults with cancer
11/12(T) 13:30-15:10
cv
Jung Woo Han
Yonsei University College of Medicine
cv
Jun Ah Lee
National Cancer Center
cv
Jung Ryeol Lee
Seoul National University College of Medicine
cv
Juhee Cho
Sungkyunkwan University

SP4. Next initiative for cancer immunotherapy
11/12(T) 15:20-17:00
cv
Ido Amit
Weizmann Institute of Science, Israel
cv
Jung Kyoon Choi
Korea Advanced Institute of Science and Technology (KAIST)
cv
Jae-Ho Cheong
Yonsei University College of Medicine
cv
Eui-Cheol Shin
Korea Advanced Institute of Science and Technology (KAIST)

SP5. Recent update of systemic therapy in gynecologic cancers
11/13(F) 10:30-12:10
cv
Kyung-Hee Chun
Yonsei University College of Medicine
cv
Maria Lee
Seoul National University College of Medicine
cv
Youn Jin Choi
The Catholic University of Korea College of Medicine
cv
Jin Young Kim
Keimyung University School of Medicine

SP6. Multidisciplinary translational conference
11/13(F) 10:30-12:10
cv
Han-Byoel Lee
Seoul National University College of Medicine
cv
Sungroh Yoon
Seoul National University College of Engineering
cv
Se-Hoon Lee
Sungkyunkwan University School of Medicine
cv
Semin Lee
Ulsan National Institute of Science and Technology (UNIST)

SP7. Resistance mechanisms and new target discovery
11/13(F) 13:20-15:00
cv
Michele Woei Ling Teng
QIMR Berghofer Medical Research Institute, Australia
cv
James Chih-Hsin Yang
National Taiwan University Cancer Center, Taiwan
cv
Jee Hyun Kim
Seoul National University College of Medicine
cv
Inkeun Park
Gachon University College of Medicine

SP8. 난치성 암환자의 치료를 위한 제도와 급여정책
11/13(F) 15:10-16:50
cv
Yeul Hong Kim
Korea University College of Medicine
cv
Mee Ryung Ahn
National Institute of Food and Drug Safety Evaluation
cv
Sung-Hee Ha
Health Insurance Review and Assessment Service
cv
Jeong-Hoon Lee
Seoul National University College of Medicine


Satellite Symposia (SS)

Satellite Symposium 1 (Lilly)
11/12(T) 08:30-08:50
Hisato Kawakami CV
Kindai University Faculty of Medicine, Japan
Solidity in gastric cancer treatment: The strong value of ramucirumab for advanced gastric cancer in 2nd line

Satellite Symposium 2 (AstraZeneca)
11/12(T) 08:50-09:10
Se-Hoon Lee CV
Sungkyunkwan University School of Medicine
The new era of advanced NSCLC treatment: Raising the bar for patient outcome with optimal front-line treatment

Satellite Symposium 3 (ONO/BMS)
11/12(T) 09:10-09:30
Se Hyun Kim CV
Seoul National University Bundang Hospital
At the five-year mark: Conquering cancer and giving life back to patients

Satellite Symposium 4 (MSD)
11/12(T) 12:40-13:20
Hye Ryun Kim CV
Yonsei University College of Medicine
More TOMORROWs: Pembrolizumab will double the hope for mNSCLC patients in the 1st line

Satellite Symposium 5 (Roche)
11/13(F) 12:40-13:10
Min Hee Hong CV
Yonsei University College of Medicine
Expanded benefit for 1L ES-SCLC patients with Tecentriq combination therapy

Satellite Symposium 6 (Servier)
11/13(F) 12:40-13:10
Changhoon Yoo CV
University of Ulsan College of Medicine
Liposomal irinotecan in metastatic pancreatic cancer: Asian and Korean experiences

top